TY - JOUR
AU - M. Ude
AU - C. N. Behrends
AU - S. Kelly
AU - B. R. Schackman
AU - A. Clear
AU - R. Goldberg
AU - K. Gelberg
AU - S. N. Kapadia
A1 - 
AD - Weill Cornell Medical College, New York, NY, 10065, USA.;Department of Population Health Sciences, Weill Cornell Medical College, New York, NY, 10065, USA.;New York State Department of Health, New York, NY, 10007, USA.;Department of Population Health Sciences, Weill Cornell Medical College, New York, NY, 10065, USA. shk9078@med.cornell.edu.;Division of Infectious Diseases, Weill Cornell Medical College, New York, NY, 10065, USA. shk9078@med.cornell.edu.
AN - 36732773
BT - Harm Reduct J
C5 - Opioids & Substance Use;Education & Workforce
CP - 1
DA - Feb 2
DO - 10.1186/s12954-023-00742-9
DP - NLM
ET - 20230202
IS - 1
JF - Harm Reduct J
LA - eng
PY - 2023
SN - 1477-7517
SP - 12
ST - The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study
T1 - The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study
T2 - Harm Reduct J
TI - The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study
U1 - Opioids & Substance Use;Education & Workforce
U3 - 10.1186/s12954-023-00742-9
VL - 20
VO - 1477-7517
Y1 - 2023
ER -